GPNMB is expressed by activated microglia and is involved in phagocytosis of pathological material; elevated GPNMB levels correlate with disease severity in Parkinson’s disease and lysosomal dysfunction in neurodegeneration [54,55]. The gene discussed is GPNMB; the disease is Parkinson disease.